Immune to Cancer: The CRI Blog
-
CICON18 Day 3 Update: Targeting Tumor Mutations with Vaccine-Based Immunotherapies
The third day of CICON18 explored cutting-edge strategies to identify and target the mutated markers that distinguish…
-
Recapping the Third Annual Rational Combinations 360°
In September, experts across the immunology and immunotherapy spectrum convened in Philadelphia to discuss the latest advances…
-
Previewing the 2018 Rational Combinations 360 Conference
The third installment of the Rational Combinations 360 conference, which will be held in Philadelphia September 13-14,…
-
ASCO18 Update: Using Biomarkers to Improve Immunotherapy
The final day of ASCO18 focused on biomarkers’ potential to improve immunotherapy as well as the next-generation…
-
ASCO18 Update: Much Ado About Melanoma (and Lung Cancer, Too)
Day 4 of ASCO18 focused on the past, present, and future of melanoma treatment, and also revealed…
-
ASCO18 Update: Immunotherapy Progress in Lung Cancer, New Promise in Ovarian Cancer
Day 3 of ASCO18 revealed more of immunotherapy’s benefits in lung cancer, especially as a first-line option,…
-
ASCO18 Update: Enhancing the Immune System’s Power Through Combination Therapies
Day 2 of ASCO18 highlighted a number of combinations and novel agents that aimed to improve immunotherapy’s…
-
30 Days of CRI Impact
Throughout Cancer Immunotherapy Month in June we’ll be highlighting the 30 most important CRI-funded breakthroughs.
-
AACR18 Recap: Immunotherapy in the Spotlight
Immunotherapy took center stage and dominated the headlines at AACR18.